Literature DB >> 25919847

Pharmacotherapy for borderline patients: business as usual or by default?

Theo Ingenhoven1.   

Abstract

In their analysis of a representative sample from the Prescribing Observatory for Mental Health in the UK health services, Paton et al found that 92% of patients with borderline personality disorder (BPD) received prescriptions for psychotropic medications. Although international guidelines recommend pharmacotherapy for comorbid psychiatric disorders whenever necessary, 82% of the UK BPD patients without such comorbid conditions nevertheless received pharmacotherapy "by default," mostly off-label polypharmacy without adequate psychiatric controls for effectiveness and tolerability. Business as usual? Bad care? International practice guidelines for the treatment of BPD all recommend evidence-based psychological treatment whenever possible (especially manualized psychotherapy like dialectical behavior therapy, schema-focused therapy, mentalization-based treatment, transference-focused psychotherapy) as the first-choice treatment. © Copyright 2015 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919847     DOI: 10.4088/JCP.14com09522

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

Review 1.  What Works in the Treatment of Borderline Personality Disorder.

Authors:  Lois W Choi-Kain; Ellen F Finch; Sara R Masland; James A Jenkins; Brandon T Unruh
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-03

Review 2.  Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies.

Authors:  Jutta Stoffers-Winterling; Ole Jakob Storebø; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2020-06-05       Impact factor: 5.285

3.  Selective Serotonin Reuptake-Inhibitors for Symptom-Based Treatment of Borderline Personality Disorders in Older Adults: An International Delphi Study.

Authors:  Julie Schulkens; Nina Bergs; Theo Ingenhoven; Erlene Rosowsky; Sebastiaan van Alphen; Sjacko Sobczak
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-02-28       Impact factor: 2.582

4.  "Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder.

Authors:  Joaquim Soler; Elisabet Casellas-Pujol; Isabel Fernández-Felipe; Ana Martín-Blanco; David Almenta; Juan C Pascual
Journal:  Acta Psychiatr Scand       Date:  2022-02-04       Impact factor: 7.734

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.